By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences last night filed its first-quarter financial results with the US Securities and Exchange Commission, reporting a drop in revenues of just over 50 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.